Case Presentations: Managing Pain in Patients With Multiple Health Problems
(Universal Program Number
084-000-002-6-H01)
Gary E. Ruoff, MD
Clinical Professor of Family Practice
Michigan State University
College of Medicine
East Lansing, Michigan
Fee: There is no charge
for participating in this educational activity.
Term of Offering:
CME/CE credit for this Internet Audioconference will
be available through January 31, 2003. The original release of this
material was February 1, 2002. CME/CE credit is offered upon successful
completion of the post-test.
Faculty Biography
Gary E. Ruoff, MD
Dr. Gary Ruoff is a Clinical Professor of Family Practice
at Michigan State University College of Medicine in East Lansing,
Michigan. Dr. Ruoff is in private practice as Medical Director of
Clinical Research at the West Side Medical Center in Kalamazoo,
Michigan. He is a member of multiple prestigious medical organizations.
Dr. Ruoff is also the author of many highly esteemed medical articles
including “Management of Pain in Patients with Multiple Health Problems:
A Guide for the Practicing
Physician”. He has achieved many honors within medicine
such as having been the recipient of the
Michigan Family Physician of the Year and the Outstanding
Family Practice teacher of the Year.
Back to Top Learning Objectives After completion of this program, participants should be able to:
Identify adverse clinical
effects that may arise with the use of conventional NSAIDs or COX-2
inhibitors in patients with comorbid conditions, such as hypertension,
congestive heart failure, diabetes, and gastropathy
Discuss strategies for managing patients with comorbid conditions who require pain management with a conventional
NSAID or COX-2 inhibitor
Describe practical considerations and guidelines for managing acute and chronic pain in the elderly
Discuss the GI safety and efficacy of the COX-2 inhibitors in the multimodal management of acute and chronic pain
Back to Top Faculty DisclosureGary E. Ruoff, MD
Formal advisor: Ortho-McNeil Pharmaceutical, Inc.; Glaxo
Wellcome Inc.; Pharmacia Corporation;
AstraZeneca; Elan Pharma; Merck & Co., Inc. Researcher:
Ortho-McNeil Pharmaceutical, Inc.; Glaxo Wellcome Inc.; Pharmacia
Corporation;
AstraZeneca; Elan Pharma; Merck & Co., Inc. Speakers’
bureau: Ortho-McNeil Pharmaceutical, Inc.; Glaxo Wellcome Inc.;
Pharmacia Corporation;
AstraZeneca; Elan Pharma; Merck & Co., Inc.
Back to TopPragmaton Office of Medical Education Privacy Policy
The Pragmaton Office of Medical
Education (POME) does not sell or offer any user data, including
registration or billing information to any third party for commercial
purposes. POME does, where required, provide the minimum subset of
information to those third parties that are responsible for
accreditation and issuance of certification of Continuing Education
tests submitted. You agree that POME has full permission to provide this
minimum subset of information to the third parties as required by
law.
To provide additional security in those cases where a credit
card number or other form of payment has been submitted, POME utilizes
this information once, but does not permanently store this information.
Therefore, it will be necessary for you to reenter billing information
during subsequent visits. Although this may create a minor
inconvenience, POME believes that security should be first and foremost
in the provision of its services and therefore will not store billing
information permanently in its records.
Back to Top